| |
| |
|
| Insider
Information: |
Bermingham Nessan |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
493,364 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$11,208,795 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
493,364 |
|
|
| Total
Value |
$11,208,795 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Intellia Therapeutics, Inc. |
NTLA |
President & CEO, Direc... |
2017-12-08 |
458,250 |
2016-05-11 |
0 |
Premium* |
|
|
F-star Therapeutics, Inc |
FSTX |
Director |
2023-03-08 |
0 |
2021-02-01 |
0 |
Premium* |
|
|
Korro Bio |
KRRO |
|
2023-11-03 |
35,114 |
2023-11-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
10 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KRRO |
Korro Bio |
|
– • – |
2023-11-03 |
4 |
A |
$0.00 |
$0 |
D/D |
35,114 |
35,114 |
0 |
- |
|
| FSTX |
F-star Therapeutics, Inc |
Director |
– • – |
2023-03-08 |
4 |
D |
$7.12 |
$45,055 |
D/D |
(6,328) |
0 |
0 |
- |
|
| FSTX |
F-star Therapeutics, Inc |
Director |
– • – |
2023-03-08 |
4 |
D |
$7.12 |
$694,535 |
D/D |
(97,547) |
6,328 |
0 |
- |
|
| FSTX |
F-star Therapeutics, Inc |
Director |
– • – |
2021-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
87,000 |
103,875 |
0 |
- |
|
| FSTX |
F-star Therapeutics, Inc |
Director |
– • – |
2020-11-20 |
4/A |
A |
$0.00 |
$0 |
D/D |
16,875 |
16,875 |
0 |
- |
|
| NTLA |
Intellia Therapeutics, In... |
President & CEO |
• • – |
2017-12-08 |
4 |
AS |
$20.82 |
$1,960,151 |
D/D |
(94,143) |
458,250 |
0 |
- |
|
| NTLA |
Intellia Therapeutics, In... |
President & CEO |
• • – |
2017-12-07 |
4 |
AS |
$21.05 |
$2,771,867 |
D/D |
(131,140) |
552,393 |
0 |
- |
|
| NTLA |
Intellia Therapeutics, In... |
President & CEO |
• • – |
2017-12-06 |
4 |
AS |
$20.28 |
$2,268,001 |
D/D |
(111,500) |
683,533 |
0 |
- |
|
| NTLA |
Intellia Therapeutics, In... |
President & CEO |
• • – |
2017-06-01 |
4 |
A |
$11.95 |
$100,379 |
D/D |
8,400 |
795,033 |
0 |
- |
|
| NTLA |
Intellia Therapeutics, In... |
President & CEO |
• • – |
2016-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
437,019 |
786,633 |
0 |
- |
|
10 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
